Comparison of CD4/6 inhibitors, PI3K inhibitors, and mTOR inhibitors for patients with advanced HR+/HER2‐ Breast cancer: A network meta‐analysis of 19 RCTs.
Saved in:
| Title: | Comparison of CD4/6 inhibitors, PI3K inhibitors, and mTOR inhibitors for patients with advanced HR+/HER2‐ Breast cancer: A network meta‐analysis of 19 RCTs. |
|---|---|
| Authors: | Wang, Lida1, Da, Huo2, Li, Xiulian3, Ran, Xuehong4, Wu, Wei5, Sheng, Zhixin4 shengzhixin5569@126.com |
| Source: | Breast Journal. Sep2020, Vol. 26 Issue 9, p1862-1866. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1075122X |
|---|---|
| DOI: | 10.1111/tbj.13780 |
